CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Amgen Inc 's Total Debt to Equity

AMGN's quarterly Total Debt to Equity and Total Debt, Equity growth




AMGN Total Debt to Equity (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Equity Change -1.59 % -2.73 % 0.29 % -1.25 % -12.44 %
Y / Y Total Debt Change 2.63 % 10.31 % 15.09 % 11.79 % -3.56 %
Total Debt to Equity MRQ 3.5 3.51 3.13 3.21 3.36
Overall Ranking # # # # #
Seq. Equity Change -0.8 % -14.14 % 2.81 % 12.38 % -1.94 %
Seq. Total Debt Change -0.91 % -3.79 % 0.18 % 7.46 % 6.5 %



Total Debt to Equity first quarter 2021 Comment
Due to debt repayement of -0.91% Amgen Inc improved Total Debt to Equity in first quarter 2021 to 3.5, above company's average Total Debt to Equity.

Within Biotechnology & Drugs industry in the first quarter 2021, 92 other companies have achieved lower Total Debt to Equity than Amgen Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Debt to Equity Ratio?
Where is AMGN most successful ?
Total Debt to Equity AMGN on the trailing twelve month basis
Total Debt to Equity first quarter 2021 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 93
Healthcare Sector # 428
Overall Market # 2969


Total Debt to Equity Statistics
High Average Low
3.51 1.09 0.16
(Dec 31 2020)   (Sep. 30, 2004)




Financial Statements
Amgen Inc 's Equity $ 9,334 Millions Visit AMGN's Balance sheet
Amgen Inc 's Total Debt $ 32,685 Millions Visit AMGN's Balance sheet
Source of AMGN's Sales Visit AMGN's Sales by Geography




Companies with similar Total Debt to Equity in the quarter endingMar 31 2021, within Biotechnology & Drugs Industry Total Debt to EquityMar 31 2021 MRQ Total DebtMar 31 2021 MRQ Equity
Abbvie Inc   6.23 $ 85,530.000  Millions$ 13,733.000  Millions
Genocea Biosciences Inc   5.48 $ 9.649  Millions$ 1.762  Millions
Pactiv Evergreen Inc   3.82 $ 3,918.000  Millions$ 1,026.000  Millions
Protalix Biotherapeutics inc   3.82 $ 55.372  Millions$ 14.504  Millions
Eloxx Pharmaceuticals Inc   3.81 $ 10.475  Millions$ 2.750  Millions
Amgen Inc   3.50 $ 32,685.000  Millions$ 9,334.000  Millions
Cidara Therapeutics Inc   3.13 $ 5.916  Millions$ 1.892  Millions
Coherus Biosciences inc   2.96 $ 378.277  Millions$ 127.671  Millions
Axim Biotechnologies Inc   2.49 $ 4.059  Millions$ 1.629  Millions
Pulse biosciences inc   2.02 $ 41.118  Millions$ 20.397  Millions
Avantor Inc   1.65 $ 4,632.800  Millions$ 2,806.100  Millions
Gilead Sciences Inc   1.59 $ 30,166.000  Millions$ 18,964.000  Millions
Aziyo Biologics Inc   1.47 $ 24.151  Millions$ 16.444  Millions
Aptevo Therapeutics Inc   1.41 $ 14.781  Millions$ 10.504  Millions
Reynolds Consumer Products Inc   1.29 $ 2,127.000  Millions$ 1,643.000  Millions
Acorda Therapeutics inc   1.15 $ 236.903  Millions$ 206.279  Millions
Nanostring Technologies Inc   0.95 $ 224.070  Millions$ 236.392  Millions
Adma Biologics Inc   0.83 $ 93.413  Millions$ 112.504  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VNGE's Profile

Stock Price

VNGE's Financials

Business Description

Fundamentals

Charts & Quotes

VNGE's News

Suppliers

VNGE's Competitors

Customers & Markets

Economic Indicators

VNGE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071